Bill description

SB 96

Defines “cannabinoids” for purpose of inhalant delivery systems. Authorizes Oregon Health Authority to consult with Oregon Liquor Control Commission on adoption of rules related to inhalant delivery systems containing cannabinoids. Authorizes commission to regulate testing and labeling of inhalant delivery systems that contain cannabinoids derived from industrial hemp.

Bill Status

Public Hearing scheduled 2/1